Research output per year
Research output per year
- 1 - 50 out of 164 results
Search results
-
2025
A Difficult Conversation
Geynisman, D. M., Apr 2025, In: JNCCN Journal of the National Comprehensive Cancer Network. 23, 4, e250019.Research output: Contribution to journal › Editorial
Open Access -
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma
Apolo, A. B., Ballman, K. V., Sonpavde, G., Berg, S., Kim, W. Y., Parikh, R., Teo, M. Y., Sweis, R. F., Geynisman, D. M., Grivas, P., Chatta, G., Reichert, Z. R., Kim, J. W., Bilen, M. A., McGregor, B., Singh, P., Tripathi, A., Cole, S., Simon, N. & Niglio, S. & 20 others, , Jan 2 2025, In: New England Journal of Medicine. 392, 1, p. 45-55 11 p.Research output: Contribution to journal › Article › peer-review
38 Scopus citations -
A New Administration and JNCCN
Geynisman, D. M., Mar 2025, In: Journal of the National Comprehensive Cancer Network. 23, 3, p. 65-65 1 p.Research output: Contribution to journal › Editorial
-
Changes for JNCCN in 2025
Geynisman, D. M., Jan 2025, In: Journal of the National Comprehensive Cancer Network : JNCCN. 23, 1, e250003.Research output: Contribution to journal › Editorial
-
Comparison of Outcomes Between African American and European American Patients With Metastatic Clear Cell Renal Cell Carcinoma Receiving Immune Checkpoint Inhibitors
Kaur, J., Hasler, J. S., Handorf, E. A., Zibelman, M. R., Anari, F., Geynisman, D. M. & Ghatalia, P., Apr 2025, In: Clinical Genitourinary Cancer. 23, 2, p. 102304 102304.Research output: Contribution to journal › Article › peer-review
-
Estimating the Impact of Adjuvant Treatment With Nivolumab on Long-Term Survivorship Rates Compared With Surveillance in Muscle Invasive Urothelial Carcinoma: Mixture Cure Modeling Analyses of Disease-Free Survival From the Phase 3 CheckMate 274 Trial
Geynisman, D. M., Chepynoga, K., Yates, G., Tate, A., Kurt, M., Patel, M. Y., Teitsson, S., Mitra, S. & Mamtani, R., Jun 2025, In: Clinical Genitourinary Cancer. 23, 3, p. 102335 102335.Research output: Contribution to journal › Article › peer-review
-
Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meeting
Berg, S. A., La Rosa, S., Zhang, T., Pierorazio, P. M., Albiges, L., Beckermann, K. E., Campbell, M. T., Carlo, M. I., Coleman, K., George, D. J., Geynisman, D. M., Johnson, R., Jonasch, E., Maranchie, J. K., McGregor, B. A., Shapiro, D. D., Singer, E. A., Shuch, B. M., Stadler, W. M. & Tannir, N. M. & 4 others, , Mar 2025, In: Urologic Oncology: Seminars and Original Investigations. 43, 3, p. 135-146 12 p.Research output: Contribution to journal › Review article › peer-review
3 Scopus citations -
Impact of Renal Function Eligibility Criteria on Clinical Trials and Real-World Survival Outcomes Among Patients With Metastatic Renal Cell Carcinoma
Wang, X., Hasler, J., Miron, B., Wang, M., Afghahi, A., Royce, T. J. & Geynisman, D. M., Apr 16 2025, (E-pub ahead of print) In: Clinical Genitourinary Cancer. p. 102362 102362.Research output: Contribution to journal › Article › peer-review
-
NCCN Guidelines® Insights: Testicular Cancer, Version 2.2025
Gilligan, T., Lin, D. W., Adra, N., Bagrodia, A., Feldman, D. R., Yamoah, K., Aggarwal, R., Chandrasekar, T., Costa, D., Drakaki, A., Eggener, S., Emamekhoo, H., Geynisman, D. M., Graham, L., Humphrey, P., Leuva, H., Levine, E. G., Luckenbaugh, A., Maughan, B. L. & McGregor, B. & 15 others, , Apr 2025, In: JNCCN Journal of the National Comprehensive Cancer Network. 23, 4, e250018.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
One Year In
Geynisman, D. M., Jun 2025, In: JNCCN Journal of the National Comprehensive Cancer Network. 23, 6, p. 195 1 p.Research output: Contribution to journal › Comment/debate
-
Phase II Trial of Risk-Enabled Therapy after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1)
Geynisman, D. M., Abbosh, P. H., Ross, E., Zibelman, M. R., Ghatalia, P., Anari, F., Mark, J. R., Stamatakis, L., Hoffman-Censits, J. H., Viterbo, R., Greenberg, R. E., Churilla, T. M., Horwitz, E. M., Hallman, M. A., Smaldone, M. C., Uzzo, R., Chen, D. Y. T., Kutikov, A. & Plimack, E. R., Mar 20 2025, In: Journal of Clinical Oncology. 43, 9, p. 1113-1122 10 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations -
Precious Time
Geynisman, D. M., May 1 2025, In: Journal of the National Comprehensive Cancer Network : JNCCN. 23, 5, p. 131 1 p.Research output: Contribution to journal › Article › peer-review
-
Serious Illness Conversations and Advance Care Planning: Can Machine-Learning or AI Really Help?
Geynisman, D. M., Feb 2025, In: JNCCN Journal of the National Comprehensive Cancer Network. 23, 2, p. 1 1 p.Research output: Contribution to journal › Comment/debate
1 Scopus citations -
2024
Androgen production, uptake, and conversion (APUC) genes define prostate cancer patients with distinct clinical outcomes
Bergom, H. E., Boytim, E., McSweeney, S., Sadeghipour, N., Elliott, A., Passow, R., Toye, E., Li, X., Likasitwatanakul, P., Geynisman, D. M., Dehm, S. M., Halabi, S., Sharifi, N., Antonarakis, E. S., Ryan, C. J. & Hwang, J., Sep 22 2024, In: JCI insight. 9, 20, e183158.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Artificial Intelligence and Oncology
Geynisman, D. M., Jul 1 2024, In: JNCCN Journal of the National Comprehensive Cancer Network. 22, 5, p. 277 1 p.Research output: Contribution to journal › Editorial
-
Author Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial
Li, R., Shah, P. H., Stewart, T. F., Nam, J. K., Bivalacqua, T. J., Lamm, D. L., Uchio, E. M., Geynisman, D. M., Jacob, J. M., Meeks, J. J., Dickstein, R., Pearce, S. M., Kang, S. H., Jung, S. I., Kamat, A. M., Burke, J. M., Keegan, K. A. & Steinberg, G. D., Jul 2024, In: Nature Medicine. 30, 8, p. 2372 1 p.Research output: Contribution to journal › Comment/debate
Open Access2 Scopus citations -
Cancer Health Disparities
Geynisman, D. M., Aug 1 2024, In: Journal of the National Comprehensive Cancer Network : JNCCN. 22, 6, p. 363-364 2 p.Research output: Contribution to journal › Editorial
-
"Cancer's a demon": a qualitative study of fear and multilevel factors contributing to cancer treatment delays
Frosch, Z., Jacobs, L., O'Brien, C., Brecher, A., McKeown, C., Lynch, S., Geynisman, D., Hall, M., Edelman, M., Bleicher, R. & Fang, C., Jan 2024, In: Supportive Care in Cancer. 32, 1, p. 13 14 p., 13.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Contemporary role of avelumab first-line maintenance in advanced urothelial carcinoma with consideration of the JAVELIN Bladder 100 comprehensive clinical subgroup analyses
Zarrabi, K. K., Miron, B. & Geynisman, D. M., Mar 31 2024, In: Translational Andrology and Urology. 13, 3, p. 405-466 62 p.Research output: Contribution to journal › Editorial
Open Access -
Hello JNCCN Readers
Geynisman, D., Jun 2024, In: Journal of the National Comprehensive Cancer Network. 22, 2D, 1 p., e240031.Research output: Contribution to journal › Editorial
Open Access -
Hope and Uncertainty in Advanced Cancers
Geynisman, D. M., Sep 1 2024, In: Journal of the National Comprehensive Cancer Network : JNCCN. 22, 7, p. 437 1 p.Research output: Contribution to journal › Comment/debate
-
Introducing the New Editor-in-Chief
Tempero, M. & Geynisman, D. M., May 2024, In: JNCCN Journal of the National Comprehensive Cancer Network. 22, 4, p. 205 1 p.Research output: Contribution to journal › Editorial
-
Investigating the Role of African Genetic Ancestry in Cardiovascular Complications and Cardiotoxicity among PatientsWith Prostate Cancer Post TreatmentWith Androgen Deprivation Therapy
Ragin, C. & Geynisman, D., Jan 2024, In: Journal of the National Comprehensive Cancer Network : JNCCN. 22, 1 DResearch output: Contribution to journal › Article › peer-review
Open Access -
Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma: A Comparative Study With Papillary and Clear Cell Renal Cell Carcinomas
Wei, S., Krause, H. B., Geynisman, D. M., Elliott, A., Kutikov, A., Uzzo, R. G., Pei, J., Barata, P., Carneiro, B., Heath, E., Ryan, C., Farrell, A., Nabhan, C., Ali-Fehmi, R., Naqash, A. R., Argani, P. & McKay, R. R., Feb 2024, In: Modern Pathology. 37, 2, p. 100404 100404.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial
Li, R., Shah, P. H., Stewart, T. F., Nam, J. K., Bivalacqua, T. J., Lamm, D. L., Uchio, E. M., Geynisman, D. M., Jacob, J. M., Meeks, J. J., Dickstein, R., Pearce, S. M., Kang, S. H., Jung, S. I., Kamat, A. M., Burke, J. M., Keegan, K. A. & Steinberg, G. D., Aug 2024, In: Nature Medicine. 30, 8, p. 2216-2223 8 p.Research output: Contribution to journal › Article › peer-review
20 Scopus citations -
Progress in Cancer 2024
Geynisman, D. M., Nov 2024, In: JNCCN Journal of the National Comprehensive Cancer Network. 22, 9, p. 581 1 p.Research output: Contribution to journal › Comment/debate
-
Publisher Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial (Nature Medicine, (2024), 10.1038/s41591-024-03025-3)
Li, R., Shah, P. H., Stewart, T. F., Nam, J. K., Bivalacqua, T. J., Lamm, D. L., Uchio, E. M., Geynisman, D. M., Jacob, J. M., Meeks, J. J., Dickstein, R., Pearce, S. M., Kang, S. H., Jung, S. I., Kamat, A. M., Burke, J. M., Keegan, K. A. & Steinberg, G. D., Jul 2 2024, In: Nature Medicine. 30, p. 2377Research output: Contribution to journal › Comment/debate
-
Racial differences in real-world outcomes of first-line therapies for advanced renal cell carcinoma
Geynisman, D. M., John, W. S., Miller, T. A., Asgarisabet, P., Guttenplan, S. B., Yin, X., Savill, K. M. Z., Mcallister, L. & Rosenblatt, L., Dec 19 2024, In: Oncologist. 5 p.Research output: Contribution to journal › Article › peer-review
-
Renal cell carcinoma histologic subtypes exhibit distinct transcriptional profiles
Barata, P., Gulati, S., Elliott, A., Hammers, H. J., Burgess, E. F., Gartrell, B. A., Darabi, S., Bilen, M. A., Basu, A., Geynisman, D. M., Dawson, N. A., Zibelman, M. R., Zhang, T., Wei, S., Ryan, C. J., Heath, E. I., Poorman, K. A., Nabhan, C. & McKay, R. R., Mar 23 2024, In: Journal of Clinical Investigation. 134, 11Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Role of Gut Microbiome in Neoadjuvant Chemotherapy Response in Urothelial Carcinoma: A Multi-institutional Prospective Cohort Evaluation
Bukavina, L., Ginwala, R., Eltoukhi, M., Sindhani, M., Prunty, M., Geynisman, D. M., Ghatalia, P., Valentine, H., Calaway, A., Correa, A. F., Brown, J. R., Mishra, K., Plimack, E. R., Kutikov, A., Ghannoum, M., Elshaer, M., Retuerto, M., Ponsky, L., Uzzo, R. G. & Abbosh, P. H., Jun 2024, In: Cancer Research Communications. 4, 6, p. 1505-1516 12 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Survival Outcomes in Patients With Muscle-Invasive Bladder Cancer Receiving Neoadjuvant Chemotherapy Stratified by Number of Cycles
Chakraborty, A., Hasler, J., Handorf, E., Anari, F., Ghatalia, P., Miron, B., Plimack, E. R., Geynisman, D. M. & Zibelman, M., Dec 2024, In: Clinical Genitourinary Cancer. 22, 6, p. 102218 102218.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
The Oncologist Outside the Exam Room
Geynisman, D. M., Dec 2024, In: JNCCN Journal of the National Comprehensive Cancer Network. 22, 10, p. 645-646 2 p.Research output: Contribution to journal › Editorial
-
Treatment Patterns and Costs among Patients with Metastatic Renal Cell Carcinoma in the United States: A Real-World Study Using Integrated Claims and Clinical Data
Geynisman, D. M., Hill, N. R., Rosenblatt, L. C., Yin, X., Haley, V. B., Barron, J. J., Nguyen, C., Vilanova, D. & George, S., 2024, (Accepted/In press) In: JCO Oncology Practice. 1-9.Research output: Contribution to journal › Article › peer-review
-
Urine Biopsy as Dynamic Biomarker to Enhance Clinical Staging of Bladder Cancer in Radical Cystectomy Candidates
Satyal, U., Valentine, H., Liu, D., Slifker, M., Lallas, C. D., Trabulsi, E. J., Bukavina, L., Szeto, L., Hoffman-Censits, J. H., Mouw, K. W., Faltas, B. M., Grivas, P., Ibragimova, I., Porten, S. P., Van Allen, E. M., Geynisman, D. M., Parker, D. C., O'Neill, J. P., Drevik, J. & Christianson, S. S. & 9 others, , Jun 1 2024, In: JCO Precision Oncology. 8, p. e2300362 e2300362.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Welcome New Fellows!
Geynisman, D. M., Oct 2024, In: Journal of the National Comprehensive Cancer Network : JNCCN. 22, 8, p. 511 1 p.Research output: Contribution to journal › Editorial
-
2023
A Matching-adjusted Indirect Comparison of Nivolumab Plus Cabozantinib Versus Pembrolizumab Plus Axitinib in Patients with Advanced Renal Cell Carcinoma
McGregor, B., Geynisman, D. M., Burotto, M., Suárez, C., Bourlon, M. T., Barata, P. C., Gulati, S., Huo, S., Ejzykowicz, F., Blum, S. I., Del Tejo, V., Hamilton, M., May, J. R., Du, E. X., Wu, A., Kral, P., Ivanescu, C., Chin, A., Betts, K. A. & Lee, C. H. & 3 others, , Jun 1 2023, In: EUROPEAN UROLOGY ONCOLOGY. 6, 3, p. 339-348 10 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors
Zibelman, M., MacFarlane, A. W., Costello, K., McGowan, T., O’Neill, J., Kokate, R., Borghaei, H., Denlinger, C. S., Dotan, E., Geynisman, D. M., Jain, A., Martin, L., Obeid, E., Devarajan, K., Ruth, K., Alpaugh, R. K., Dulaimi, E. A. S., Cukierman, E., Einarson, M. & Campbell, K. S. & 1 others, , Jun 27 2023, In: Nature Communications. 14, 1, p. 4513 4513.Research output: Contribution to journal › Article › peer-review
Open Access15 Scopus citations -
A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study
Hahn, N. M., O'Donnell, M. A., Efstathiou, J. A., Zahurak, M., Rosner, G. L., Smith, J., Kates, M. R., Bivalacqua, T. J., Tran, P. T., Song, D. Y., Baras, A. S., Matoso, A., Choi, W., Smith, K. N., Pardoll, D. M., Marchionni, L., McGuire, B., Grace Phelan, M., Johnson, B. A. & O'Neal, T. & 21 others, , Jun 2023, In: European Urology. 83, 6, p. 486-494 9 p.Research output: Contribution to journal › Article › peer-review
30 Scopus citations -
A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer
Pook, D., Geynisman, D. M., Carles, J., de Braud, F., Joshua, A. M., Pérez-Gracia, J. L., Pérez, C. L., Shin, S. J., Fang, B., Barve, M., Maruzzo, M., Bracarda, S., Kim, M., Kerloeguen, Y., Gallo, J. D., Maund, S. L., Harris, A., Huang, K. C., Poon, V. & Sutaria, D. S. & 1 others, , Sep 1 2023, In: Clinical Cancer Research. 29, 17, p. 3292-3300 9 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy
Jang, H. J., Hostetter, G., MacFarlane, A. W., Madaj, Z., Ross, E. A., Hinoue, T., Kulchycki, J. R., Burgos, R. S., Tafseer, M., Alpaugh, R. K., Schwebel, C. L., Kokate, R., Geynisman, D. M., Zibelman, M. R., Ghatalia, P., Nichols, P. W., Chung, W., Madzo, J., Hahn, N. & Quinn, D. I. & 7 others, , Jun 1 2023, In: Clinical Cancer Research. 29, 11, p. 2052-2065 14 p.Research output: Contribution to journal › Article › peer-review
Open Access22 Scopus citations -
Between the Hammer and Anvil: Resolution of unresectable muscle invasive bladder cancer in a renal transplant patient after cessation of immunosuppressive therapy
Strauss, D., Kaplunov, B., Kutikov, A., Geynisman, D. M., Lau, K. & Smaldone, M., May 2023, In: Urology Case Reports. 48, p. 102399 102399.Research output: Contribution to journal › Article › peer-review
Open Access -
Comparative Effectiveness of Front-Line Ipilimumab and Nivolumab or Axitinib and Pembrolizumab in Metastatic Clear Cell Renal Cell Carcinoma
Zarrabi, K. K., Handorf, E., Miron, B., Zibelman, M. R., Anari, F., Ghatalia, P., Plimack, E. R. & Geynisman, D. M., Feb 8 2023, In: Oncologist. 28, 2, p. 157-164 8 p.Research output: Contribution to journal › Article › peer-review
Open Access17 Scopus citations -
Corrigendum to real-world treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in the United States [Urologic oncology: Seminars and original investigations 40 (2022) 195.e1−195.e11] (Urologic Oncology: Seminars and Original Investigations (2022) 40(5) (195.e1–195.e11), (S107814392100510X), (10.1016/j.urolonc.2021.11.014))
Geynisman, D. M., Broughton, E., Hao, Y., Zhang, Y., Le, T. & Huo, S., May 2023, In: Urologic Oncology: Seminars and Original Investigations. 41, 5, p. 259 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
Cost-Effectiveness Analysis for Therapy Sequence in Advanced Cancer: A Microsimulation Approach with Application to Metastatic Prostate Cancer
Handorf, E. A., Beck, J., Correa, A., Ramamurthy, C. & Geynisman, D., 2023, In: Medical Decision Making. 43, 7-8, p. 949-960 12 p., 0272989X231201621.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Current Status and Future Direction to Address Disparities in Diversity, Equity, and Inclusion in Prostate Cancer Care
Fu, J., Fu, C., Wang, R. S., Geynisman, D. M., Ghatalia, P., Lynch, S. M., Harrison, S. R., Tagai, E. K. & Ragin, C., Jul 2023, In: Current Oncology Reports. 25, 7, p. 699-708 10 p.Research output: Contribution to journal › Review article › peer-review
Open Access6 Scopus citations -
Development of a Multilevel Model to Identify Patients at Risk for Delay in Starting Cancer Treatment
Frosch, Z. A. K., Hasler, J. S., Handorf, E., DuBois, T., Bleicher, R. J., Edelman, M. J., Geynisman, D. M., Hall, M. J., Fang, C. Y. & Lynch, S. M., Aug 1 2023, In: JAMA network open. 6, 8, p. e2328712 e2328712.Research output: Contribution to journal › Article › peer-review
Open Access10 Scopus citations -
Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer
O'Donnell, P. H., Milowsky, M. I., Petrylak, D. P., Hoimes, C. J., Flaig, T. W., Mar, N., Moon, H. H., Friedlander, T. W., McKay, R. R., Bilen, M. A., Srinivas, S., Burgess, E. F., Ramamurthy, C., George, S., Geynisman, D., Bracarda, S., Borchiellini, D., Geoffrois, L., Rey, J. P. M. & Ferrario, C. & 5 others, , Aug 1 2023, In: Journal of Clinical Oncology. 41, 25, p. 4107-4117 11 p.Research output: Contribution to journal › Article › peer-review
Open Access112 Scopus citations -
Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer
Madan, R. A., Bilusic, M., Stein, M. N., Donahue, R. N., Arlen, P. M., Karzai, F., Plimack, E., Wong, Y. N., Geynisman, D. M., Zibelman, M., Mayer, T., Strauss, J., Chen, G., Rauckhorst, M., Mcmahon, S., Couvillon, A., Steinberg, S., Figg, W. D., Dahut, W. & Schlom, J. & 1 others, , Jul 1 2023, In: Oncologist. 28, 7, p. 642-E561Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
Grade 3/4 Adverse Event Costs of Immuno-oncology Combination Therapies for Previously Untreated Advanced Renal Cell Carcinoma
McGregor, B., Geynisman, D. M., Burotto, M., Porta, C., Suarez, C., Bourlon, M. T., Del Tejo, V., Du, E. X., Yang, X., Sendhil, S. R., Betts, K. A. & Huo, S., Jan 2023, In: Oncologist. 28, 1, p. 72-79 8 p.Research output: Contribution to journal › Article › peer-review
Open Access10 Scopus citations -
Neoadjuvant Chemotherapy with Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Patients with Muscle-invasive Bladder Cancer: A Retrospective Age-stratified Analysis on Safety and Efficacy
Hemenway, G., Lewis, B., Ghatalia, P., Anari, F., Plimack, E. R., Kokate, R., Handorf, E., Deng, M., Geynisman, D. M. & Zibelman, M., Aug 1 2023, In: EUROPEAN UROLOGY ONCOLOGY. 6, 4, p. 431-436 6 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations